ATE119766T1 - Zubereitung für den magen. - Google Patents

Zubereitung für den magen.

Info

Publication number
ATE119766T1
ATE119766T1 AT90915816T AT90915816T ATE119766T1 AT E119766 T1 ATE119766 T1 AT E119766T1 AT 90915816 T AT90915816 T AT 90915816T AT 90915816 T AT90915816 T AT 90915816T AT E119766 T1 ATE119766 T1 AT E119766T1
Authority
AT
Austria
Prior art keywords
desirably
release portion
stomach
preparation
administration
Prior art date
Application number
AT90915816T
Other languages
English (en)
Inventor
Kouichi Ushimaru
Kouichi Nakamichi
Hiroyuki Yasuura
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE119766T1 publication Critical patent/ATE119766T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90915816T 1989-10-26 1990-10-24 Zubereitung für den magen. ATE119766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27929389 1989-10-26

Publications (1)

Publication Number Publication Date
ATE119766T1 true ATE119766T1 (de) 1995-04-15

Family

ID=17609152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915816T ATE119766T1 (de) 1989-10-26 1990-10-24 Zubereitung für den magen.

Country Status (5)

Country Link
US (1) US5368861A (de)
EP (1) EP0497977B1 (de)
AT (1) ATE119766T1 (de)
DE (1) DE69017915T2 (de)
WO (1) WO1991006281A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
AU7994694A (en) * 1994-10-21 1996-05-15 Leiras Oy Controlled release oral delivery system containing oxybutynin
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
AU3290397A (en) * 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
ES2129356B1 (es) * 1997-03-26 2000-01-16 Pierre Fabre Iberica S A Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6171615B1 (en) 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
US6492488B1 (en) * 1998-08-02 2002-12-10 Pmd Holdings Corp. Controlled release polyacrylic acid granules and a process for preparing the same
CA2313504C (en) * 1999-07-12 2007-05-29 Douglas P. Debernardi Folic acid in solid dosage forms
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
MXPA04003002A (es) * 2001-10-08 2004-07-15 Sun Pharmaceutical Ind Ltd Un sistema de administracion espacial de farmacos para agentes antiespasmodicos.
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
ITMI20022343A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
DE102005011029A1 (de) * 2005-03-08 2006-09-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen
JPWO2007069358A1 (ja) * 2005-12-14 2009-05-21 キッセイ薬品工業株式会社 新規胃内滞留製剤
CA2673485A1 (en) * 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. Gastric retention-type sustained-release levodopa preparation
WO2009114648A1 (en) * 2008-03-11 2009-09-17 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
EP2163240A1 (de) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova Verfahren zur Herstellung von bioadhesiven Kompaktmatrizen
JP5594484B2 (ja) 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
MX356789B (es) * 2013-01-16 2018-06-12 Invekra S A P I De C V Composición de difenidol de liberación prolongada.
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951792A (en) * 1959-11-18 1960-09-06 Smith Kline French Lab Sustained release pharmaceutical tablets
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
US4424235A (en) * 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.

Also Published As

Publication number Publication date
DE69017915D1 (de) 1995-04-20
EP0497977A4 (en) 1992-09-16
EP0497977A1 (de) 1992-08-12
DE69017915T2 (de) 1995-07-27
WO1991006281A1 (fr) 1991-05-16
EP0497977B1 (de) 1995-03-15
US5368861A (en) 1994-11-29

Similar Documents

Publication Publication Date Title
DE69017915D1 (de) Zubereitung für den magen.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
LU91037I2 (fr) Somatulina autogel
IT8619675A1 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ZA876731B (en) Therapeutic agents
FR2604090B1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
MX9203543A (es) Medicamento.
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
IL87160A0 (en) Process for producing medicinal active substances by means of a printing process
DK62187D0 (da) Farmaceutisk praeparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
FR2628971B1 (fr) Forme d'administration solide, a desagregation rapide, du diclofenac
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties